President Biden Signs H.R. 3537 in Support of ALS Research
U.S. President Joe Biden signs H.R. 3537, the Accelerating Access to Critical Therapies for ALS Act, in the Eisenhower Executive Office Building in Washington, D.C., U.S., on Thursday, Dec. 23, 2201. The Senate passed the measure to direct the secretary of Health and Human Services to support research on, and expanded access to investigational drugs for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Photo by Ken Cedeno/UPI
Please fill out form for pricing information for the photo below.